Arkolith/Insider Trading/KTRA/Form 4

Zarrabian Saiid

Head of Strategic Partnerships, DirectorKintara Therapeutics, Inc. (KTRA) · full profile →Form 4 · filed Dec 8, 2021
Net Buying
Open-Market Buys
$31K
Open-Market Sells
$0
Net Open-Market Flow
$31K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 7, 2021Buy(P)38K$0.64$24K56K
Dec 6, 2021Buy(P)12K$0.59$7K17K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-21-047320) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML